Hillstream BioPharma

Randy Milby, CEO of Hillstream BioPharma (NASDAQ: HILS), was a guest on Benzinga’s All-Access. Hillstream BioPharma is a biotechnology company developing a focused portfolio of therapeutic candidates targeting drug-resistant and devastating cancers. The company’s emerging immuno-...

A surge in oncology drug development, coupled with increased patient access and early diagnosis, has resulted in a massive increase in global spending on cancer treatments. Due to this, the global oncology market has been growing at an unprecedented pace over the past few years. According to a...

A surge in oncology drug development, coupled with increased patient access and early diagnosis, has resulted in a massive increase in global spending on cancer treatments. Due to this, the global oncology market has been growing at an unprecedented pace over the past few years. According to a...